a developer of pharmaceutical products
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYCKX | 46.65 | 0.73 | +1.59% |
Rydex S&P MidCap 400 Pure Growth C | |||
HNDRX | 77.58 | 0.19 | +0.25% |
Horizon Defined Risk Investor | |||
NASDX | 41.76 | 0.07 | +0.17% |
Shelton Nasdaq-100 Index Investor | |||
FZEMX | 39.27 | 0.04 | +0.10% |
Fidelity Advisor Emerging Markets Z | |||
SSMOX | 12.53 | N/A | N/A |
Steward Values Enhanced SmMidCapIndex R6 |
A.I.dvisor indicates that over the last year, OMER has been loosely correlated with CRSP. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if OMER jumps, then CRSP could also see price increases.
Ticker / NAME | Correlation To OMER | 1D Price Change % | ||
---|---|---|---|---|
OMER | 100% | +41.14% | ||
CRSP - OMER | 43% Loosely correlated | +3.43% | ||
VCYT - OMER | 40% Loosely correlated | +1.67% | ||
BEAM - OMER | 39% Loosely correlated | +6.23% | ||
FATE - OMER | 38% Loosely correlated | +10.63% | ||
VRDN - OMER | 38% Loosely correlated | +2.96% | ||
More |